157 related articles for article (PubMed ID: 30844686)
1. Synthesis of novel spirooxindole-pyrrolidines and evaluation of their cytotoxic activity.
Tumskiy RS; Burygin GL; Anis'kov AA; Klochkova IN
Pharmacol Rep; 2019 Apr; 71(2):357-360. PubMed ID: 30844686
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of new thiazolo-pyrrolidine-(spirooxindole) tethered to 3-acylindole as anticancer agents.
Islam MS; Ghawas HM; El-Senduny FF; Al-Majid AM; Elshaier YAMM; Badria FA; Barakat A
Bioorg Chem; 2019 Feb; 82():423-430. PubMed ID: 30508794
[TBL] [Abstract][Full Text] [Related]
3. Novel spirooxindole-pyrrolidine compounds: synthesis, anticancer and molecular docking studies.
Arun Y; Saranraj K; Balachandran C; Perumal PT
Eur J Med Chem; 2014 Mar; 74():50-64. PubMed ID: 24445312
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, antidiabetic activity and molecular docking study of rhodanine-substitued spirooxindole pyrrolidine derivatives as novel α-amylase inhibitors.
Toumi A; Boudriga S; Hamden K; Sobeh M; Cheurfa M; Askri M; Knorr M; Strohmann C; Brieger L
Bioorg Chem; 2021 Jan; 106():104507. PubMed ID: 33288322
[TBL] [Abstract][Full Text] [Related]
5. Stereoselective Synthesis of the Di-Spirooxindole Analogs Based Oxindole and Cyclohexanone Moieties as Potential Anticancer Agents.
Al-Majid AM; Ali M; Islam MS; Alshahrani S; Alamary AS; Yousuf S; Choudhary MI; Barakat A
Molecules; 2021 Oct; 26(20):. PubMed ID: 34684885
[TBL] [Abstract][Full Text] [Related]
6. Design, Synthesis and Antitumor Activity of Novel Dispiro[oxindole-cyclohexanone]- pyrrolidines.
Gouda M; Bawazeer M; Hegazy L; Azab M; Elagawany M; Rateb M; Yaseen M; Elgendy B
Curr Pharm Des; 2022; 28(3):198-207. PubMed ID: 34176458
[TBL] [Abstract][Full Text] [Related]
7. Microwave-assisted rapid synthesis of spirooxindole-pyrrolizidine analogues and their activity as anti-amyloidogenic agents.
de Silva NH; Pyreddy S; Blanch EW; Hügel HM; Maniam S
Bioorg Chem; 2021 Sep; 114():105128. PubMed ID: 34225163
[TBL] [Abstract][Full Text] [Related]
8. Spiro[pyrrolidine-3,3'-oxindoles] and Their Indoline Analogues as New 5-HT6 Receptor Chemotypes.
Kelemen ÁA; Satala G; Bojarski AJ; Keserű GM
Molecules; 2017 Dec; 22(12):. PubMed ID: 29240714
[TBL] [Abstract][Full Text] [Related]
9. Stereoselective synthesis and discovery of novel spirooxindolopyrrolidine engrafted indandione heterocyclic hybrids as antimycobacterial agents.
Arumugam N; Almansour AI; Kumar RS; Siva Krishna V; Sriram D; Dege N
Bioorg Chem; 2021 May; 110():104798. PubMed ID: 33735710
[TBL] [Abstract][Full Text] [Related]
10. The discovery of oxazolones-grafted spirooxindoles via three-component diversity oriented synthesis and their preliminary biological evaluation.
Dong H; Song S; Li J; Xu C; Zhang H; Ouyang L
Bioorg Med Chem Lett; 2015 Sep; 25(17):3585-91. PubMed ID: 26159483
[TBL] [Abstract][Full Text] [Related]
11. Spirooxindole-pyrrolidine heterocyclic hybrids promotes apoptosis through activation of caspase-3.
Kumar RS; Almansour AI; Arumugam N; Mohammad F; Kotresha D; Menéndez JC
Bioorg Med Chem; 2019 Jun; 27(12):2487-2498. PubMed ID: 30853330
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of first ever 4-quinolone-3-carboxylic acid-appended spirooxindole-pyrrolidine derivatives and their biological applications.
Arasakumar T; Mathusalini S; Ata A; Shankar R; Gopalan S; Lakshmi K; Sakthivel P; Mohan PS
Mol Divers; 2017 Feb; 21(1):37-52. PubMed ID: 27670880
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of substituted pyrrolidines and pyrroles as potential anticancer agents.
Ji J; Sajjad F; You Q; Xing D; Fan H; Reddy AGK; Hu W; Dong S
Arch Pharm (Weinheim); 2020 Dec; 353(12):e2000136. PubMed ID: 32776576
[TBL] [Abstract][Full Text] [Related]
14. Discovery of new LXRβ agonists as glioblastoma inhibitors.
Chen H; Chen Z; Zhang Z; Li Y; Zhang S; Jiang F; Wei J; Ding P; Zhou H; Gu Q; Xu J
Eur J Med Chem; 2020 May; 194():112240. PubMed ID: 32248003
[TBL] [Abstract][Full Text] [Related]
15. Facile one-pot synthesis of novel dispirooxindole-pyrrolidine derivatives and their antimicrobial and anticancer activity against A549 human lung adenocarcinoma cancer cell line.
Arun Y; Bhaskar G; Balachandran C; Ignacimuthu S; Perumal PT
Bioorg Med Chem Lett; 2013 Mar; 23(6):1839-45. PubMed ID: 23395665
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and biological evaluation of nitroisoxazole-containing spiro[pyrrolidin-oxindole] derivatives as novel glutathione peroxidase 4/mouse double minute 2 dual inhibitors that inhibit breast adenocarcinoma cell proliferation.
Liu SJ; Zhao Q; Peng C; Mao Q; Wu F; Zhang FH; Feng QS; He G; Han B
Eur J Med Chem; 2021 May; 217():113359. PubMed ID: 33725632
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological activity of 4-aryl-3-benzoyl-5-phenylspiro[pyrrolidine-2.3'-indolin]-2'-one derivatives as novel potent inhibitors of advanced glycation end product.
Kaur A; Singh B; Vyas B; Silakari O
Eur J Med Chem; 2014 May; 79():282-9. PubMed ID: 24747065
[TBL] [Abstract][Full Text] [Related]
18. [Bmim]Br Accelerated One-Pot Three-Component Cascade Protocol for the Construction of Spirooxindole-Pyrrolidine Heterocyclic Hybrids.
Kumar RS; M Al-Thamili D; Almansour AI; Arumugam N; Dege N
Molecules; 2020 Oct; 25(20):. PubMed ID: 33080968
[TBL] [Abstract][Full Text] [Related]
19. Chemo-/Regio-Selective Synthesis of Novel Functionalized Spiro[pyrrolidine-2,3'-oxindoles] under Microwave Irradiation and Their Anticancer Activity.
Sharma R; Yadav L; Nasim AA; Yadav RK; Chen RH; Kumari N; Ruiqi F; Sharon A; Sahu NK; Ippagunta SK; Coghi P; Wong VKW; Chaudhary S
Molecules; 2023 Sep; 28(18):. PubMed ID: 37764279
[TBL] [Abstract][Full Text] [Related]
20. Fe
Maddela S; Makula A; Galigniana MD; Parambi DGT; Federicci F; Mazaira G; Hendawy OM; Dev S; Mathew GE; Mathew B
Arch Pharm (Weinheim); 2019 Jan; 352(1):e1800174. PubMed ID: 30485473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
